论文部分内容阅读
本文报道了1974—1984年间接受治疗的69例成人急性淋巴细胞白血病患者(男46例,女23例),年龄16—66岁(平均30.2岁)。诊断按 FAB 标准,T 淋巴细胞白血病开始时,用羊 E-花结,近年来用单克隆抗体诊断,急性 B 淋巴细胞白血病是用特异的抗人免疫球蛋白血清诊断。治疗方案按不同时期分为以下3组。A 组(1974—1978)诱导治疗:长春新硷(VCR)(1.4mg/M~2,最大2mg)+强的松龙40mg
This article reports on 69 adult acute lymphoblastic leukemia patients (46 males and 23 females) who were treated between 1974 and 1984, aged 16-66 years (average 30.2 years). According to the FAB standard, at the beginning of T-lymphocytic leukemia, sheep E-flower buds were used. In recent years, monoclonal antibodies were used for diagnosis. Acute B-lymphocytic leukemia was diagnosed with specific anti-human immunoglobulin serum. The treatment plan was divided into the following 3 groups according to different periods. Induction treatment in group A (1974-1978): Changchun Xinjing (VCR) (1.4mg/M~2, maximum 2mg) + prednisolone 40mg